Annovis Bio, Inc.

NYSE:ANVS

4.37 (USD) • At close December 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Operating Activities:
Net Income -56.204-25.329-14.487-5.462-0.991-0.714-0.682
Depreciation & Amortization 0000.1291.19100
Deferred Income Tax 000-0.129-1.19100
Stock Based Compensation 4.6289.1534.6981.8650.0080.0830.048
Change In Working Capital 2.44-1.1370.657-0.4010.4220.0730.096
Accounts Receivables 0000.735-0.73500
Inventory 000-0.7350.73500
Accounts Payables 03.2730.346-0.6960.969-0.0030.062
Other Working Capital 2.44-4.410.3110.295-0.5480.0750.035
Other Non Cash Items 9.1695.8794.3510.0270.0840.0850.012
Operating Cash Flow -39.967-17.313-9.132-3.971-0.477-0.559-0.537
Investing Activities:
Investments In Property Plant And Equipment 0000000
Acquisitions Net 0000000
Purchases Of Investments 0000000
Sales Maturities Of Investments 0000000
Other Investing Activites 0000000
Investing Cash Flow 0000000
Financing Activities:
Debt Repayment 00000.5300
Common Stock Issued 16.8860.00546.64812.034-0.0790.0030.008
Common Stock Repurchased 0000000
Dividends Paid 0000000
Other Financing Activities 0.4580.0050.0950.009-0.0870.490.656
Financing Cash Flow 17.3440.00546.74412.0440.4430.2460.332
Other Information:
Effect Of Forex Changes On Cash 0000000
Net Change In Cash -22.623-17.30837.6118.073-0.033-0.312-0.205
Cash At End Of Period 5.75528.37845.6868.0750.0020.0350.347